Medicine & TechnologyCRISPR, introduced by Doudna and Charpentier 11 years ago, gains FDA approval for gene-editing, a groundbreaking advance in treating genetic diseases. Continue reading to learn more about the world's first gene-editing treatment for human illness.
Medicine regulators greenlight the first CRISPR therapy, Casgevy, for genetic blood disorders. Explore its approval, mechanism, and details in this article.